AVXL Operating Cash Flow (Statement)
Anavex Life Sciences Corp · Operating Cash Flow (Statement)
AVXL Operating Cash Flow (Statement)
Latest reported-$33.73Mperiod ending
AVXL Cash from Operations (-$11.89K → -$33.73M)
Annual operating cash flow (statement)
High-resolution chart · PNG
AVXL operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -39,044,000 | |
| -30,812,000 | |
| -27,785,000 | |
| -24,238,000 | |
| -30,384,000 | |
| -21,287,046 | |
| -18,527,117 | |
| -12,582,406 | |
| -9,017,231 | |
| -9,236,823 | |
| -4,227,006 | |
| -2,659,379 | |
| -777,573 | |
| -1,692,940 | |
| -3,801,479 | |
| -4,593,588 | |
| -2,794,655 | |
| -2,474,053 | |
| -325,250 | |
| -32,428 | |
| -61,072 | |
| -11,890 |